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Objective: To construct a novel plasmid as Salmonella enterica serovar typhimurium (S.
typhimurium) sipC gene knockouts candidate.
Methods: In this research, 50 upstream and 30 downstream regions of S. typhimurium
sipC gene and kanamycin gene were PCR ampliﬁed. Each of these DNA fragment was
cloned into pGEM T-easy vector. The construct was conﬁrmed by PCR and restriction
digest.
Results: PCR ampliﬁed 320, 206 and 835 bp DNA fragments were subcloned into pET-
32 vector resulting with a plasmid called pET-32-sipC up-kan- sip C down.
Conclusions: The new plasmid (pET-32-sipC up-kan- sip C down) is useful for genetic
engineering and for future manipulation of S. typhimurium sipC gene.1. Introduction
Salmonella is a member of the Enterobacteriaceae family, a
large group of Gram-negative, non-spore-forming bacilli and
facultative anaerobes [1]. Salmonella enterica (S. enterica)
causes nearly 99% of Salmonella infections in animals and
humans [2]. The S. enterica includes about 2600 diverse
serotypes which consist of two species, Salmonella bongori
and S. enterica and are divided into six subspecies: salamae,
enterica, diarizonae, arizonae, indica and houtenae [1].
S. enterica serovar typhimurium (S. typhimurium) is a widely
distributed food-borne pathogen and one of the most popular
causes of bacterial food-borne disease in humans and animals
and deaths globally [3,4]. Salmonellosis is considered one of the
most signiﬁcant food-borne zoonoses that is viewed in two kinds
of different diseases, enteric fever which can be typhoid or
paratyphoid and gastroenteritis which is non-typhoidal [5,6].
Bacterial pathogen in human causes 21 million cases of
typhoid fever and 200000 deaths per year, mainly in Southern
Asia, Africa and South America [7]. The discovery of a newvaccine for salmonellosis is a challenge for the scientists.
Several vaccines have undergone clinical tests. The need of an
efﬁcacious vaccine against salmonellosis providing strong
humoral as well as cellular immunity still persists [8].
S. enterica serovars have been classiﬁed based on reactivity of
antigen to somatic lipopolysaccharide, ﬂagellar and capsular
antigens. From a clinical aspect, these may be broadly
grouped on the basis of host range and disease representation
[9]. The Salmonella pathogenicity islands (SPIs) 1 and 2 are
two important virulence determinants of S. enterica. They
encode type III secretion systems (T3SS), which carry the
effector proteins and enable the injection of effector proteins
directly into the cytosol of eukaryotic cells. These effectors
ﬁnally manipulate the cellular functions of the infected host
and comfort the development of the infection [10]. At present,
21 SPIs have been recognized in Salmonella. Many of the
identiﬁed SPI-encoded genes have only putative functions
with no obvious role in Salmonella pathogenesis.
The SPI-1 locus is a 40 kb chromosomal island, which carries
among all the others genes needed for the biosynthesis of a
functional T3SS, a number of some effector and regulatory
proteins and their chaperones [1]. The T3SS allows the secreted
proteins to pass through the bacterial outer and inner membranes
and a translocon creates a pore in the host cell membrane [11].
Location and function of these proteins in this system are
shown below. Inner membrane proteins: InvA, SpaP, Q, R, S;rticle under the CC BY-NC-ND
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proteins: InvG, PrgK, PrgH; chaperone: SicA; putative
chaperone: InvI; secreted proteins involved in secretion: InvJ,
SpaO; secreted proteins with an effector function (target
proteins): SipA, SipB, Salmonella invasion protein C (SipC),
SipD, SptP [12].
Invasion is initiated by pathogen binding to the host cell
surface [13]. After invasion and entering the lumen of the small
intestine, environmental conditions enable T3SS-1 genes to be
expressed and subsequently the secretion system to be assembled
at the bacterial membrane [14]. Cell entry is determined by
rearrangements of the actin cytoskeleton, which is partly
interceded by SipC, a component of the bacterial translocon, at
the place of bacteria–host-cell contact [1]. SipC includes two
membrane-spanning areas with C- and N-terminal domains
front of the host-cell cytoplasm. This topological assembly of this
effector protein is a reason to the actin nucleation and the trans-
location processes. Remarkably, both of these processes are pri-
marily dependent on the C-terminus of SipC. SipC can localize
actin polymerization at bacterial attachment site and employ actin
directly [15]. Kanamycin is inactivated with the amino-
phosphotransferases by transferring the g-phosphate to the OH
group in the 30 position of the pseudosaccharide. The kan gene
was cloned and transformed in Escherichia coli (E. coli) cells [16].
The purpose of this study was to generate a plasmid that
carries kanamycin resistance gene replacement of S. typhimu-
rium native sipC gene with Up-Kan-Down fragment, using ho-
mologous recombination technique.
2. Materials and methods
2.1. Bacterial complex, plasmids construction and
media
In this study, the protocol and informed consent forms were
approved by the Islamic Azad University, Shahrekord Branch,
Shahrekord, Iran with 17621105 grant number. Virulent S.
Typhimurium (ATCC-13311) collected from Microbiology
Laboratory of Islamic Azad University of Shahrekord Branch
was preserved as frozen glycerol stocks and cultured into Luria-
Bertani (LB) broth until the log growth phase (optical density
600 = 0.9) was reached. The kan gene was isolated from the
pET-28 vector. For cloning, preservation of DNA fragment and
subcloning, pGEM T-easy vector using TA cloning kit (Prom-
ega, U.S) and pET-32 vector with E. coli strain TOP10F0 were
used, respectively. Bacterial cultures were grown at 37 C in LB
broth and LB agar plates.
2.2. Extraction of genomic DNA from S. typhimurium
DNA was isolated from colonies of bacteria using DNA
extraction kit (DNP™ Kit, CinnaGen, Iran) according to the
manufacturer's protocol. The quality of DNA was checked on 1%
agarose gel electrophoresis and quantiﬁed by spectrophotometric
mensuration at 260 nm, according to Sambrook and Russell [17].
2.3. Ampliﬁcation of ﬂanking regions of sipC gene and
kan gene
Oligonucleotide primers were designed for ampliﬁcation of
ﬂanking regions of sipC gene of S. typhimurium. The sequencesof these primers were up-sipC-F: 50-ATGTCTAGA
CCCTAAATAAAGTGGCG-30 and up-sipC-R: 50 ATTAG
ATCTCTCCCTTTATTTGGCAG-30 (accession number:
CP008928.1) containing Xba I and Bgl II restriction sites and
down-sipC-F: 50-ATTGAGCTCTGACCACTGAAAGCCAC-30
and down-sipC-R: 50-ACACTCGAGTAATACCCAGACTT
TCCG-30 (accession number: CP007360.1) containing Sac I and
Xho I restriction sites. Primers were used for ampliﬁcation of up
and down region of sipC gene, respectively. Moreover, kan-F:
50-ATAAGATCTATGAGCCATATTCAGCGTG-30 and kan-
R: 50-ATAGAGCTCTTAGAAAAATTCATCCAG-30 primers
containing Bgl II and Sac I restriction sites were designed for
ampliﬁcation of kan gene and pET-28 vector was used as tem-
plate. Underlined sequences indicate restriction sites.
Three collections of PCR programs were performed singly
in high volume for ampliﬁcation of kan gene and up and
down regions of sipC gene. PCR ampliﬁcation programs
were carried out in a total volumes of 25 mL in 0.2 mL tubes
containing 1 mL of template DNA, 1 mmol/L of each primer,
2.5 mmol/L of 10× PCR buffer, 2 mmol/L MgCl2, 200 mmol/
L deoxy-ribonucleoside triphosphate and 1 unit of Taq DNA
polymerase (Fermentas, Germany). For the optimal ampliﬁ-
cation of ﬂanking regions of sipC gene and kan gene, an
initial denaturation step was performed at 95 C for 5 min,
then ampliﬁed for 32 cycles of denaturation at 94 C for
1 min, annealing at 62 C for 1 min and extension at 72 C
for 1 min. Lastly, a ﬁnal extension phase was programmed
for 5 min at 72 C and ampliﬁed samples were held at
10 C.
2.4. Analysis of PCR products
The ampliﬁed products (10 mL) were analysed by electro-
phoresis in 1% agarose gel in tetrabromoethane [tris-base
10.8 g 89 mmol/L, boric acid 5.5 g 2 mmol/L, ethylene
diamine tetraacetic acid 4 mL of 0.5 mol/L ethylene diamine
tetraacetic acid (pH 8.0) buffer]. Constant voltage of 80 V was
used for products differentiation. The 100 bp DNA ladder
(Fermentas, Germany) was used as a molecular weight marker.
After electrophoresis, the gel was stained with ethidium bro-
mide and images were taken in UVIdoc gel documentation
systems (UK).
2.5. Cloning of sipC gene and plasmid construction
The PCR products were puriﬁed using gel extraction kit
(Bioneer, Korea) according to manufacture's protocol. All PCR
products were cloned into pGEM T-easy vector and the re-
combinant vectors were transformed by heat shock at 42 C and
calcium chloride method into E. coli TOP10F0 competent cells
in LB culture media (Merck, Germany). Kanamycin resistance
was used for the selection. The presence of ﬂanking regions of
sipC gene and kan gene was conﬁrmed by restriction endonu-
cleases analysis.
2.6. Subcloning of the sipC and kan genes
The up-sipC fragment was removed from the pGEM T-
easy vector by Xba I-Bgl II double digestion and subcloned in
Xba I-Bgl II linearized pET-32 to get pET-32-sipC up. Then,
kan fragment was released from the pGEM T-easy vector by
Figure 2. Digested pGEM recombinant plasmid.
Analysis of digested pGEM recombinant plasmid was performed using
Xba I, Bgl II, Sac I and Xho I restriction endonuclease enzymes. Line M:
1 kb DNA ladder (Fermentas, Germany); Line 1: pGEM vector with down
regions; Line 2: pGEM vector with kan gene; Lines 3: pGEM vector with
up regions; Line 4: pGEM vector without inserted sequence.
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linearized pET-32-sipC up producing pET-32-sipC up-kan.
Finally, pGEM-sipC down double digested with Sac I-Xho I
and down fragment of sipC was subcloned into Sac I-Xho I
linearized pET-32-sipC up-kan to produce pET-32-sipC up-
kan-sipC down recombinant vector. Competent cells of
E. coli TOP10F0 strain were transformed with pET-32-sipC
up-kan-sipC down recombinant vector. Flanking regions of
sipC gene and kan gene containing restriction point of Xba I,
Bgl II, Sac I and Xho I were inserted in polyclonal site in
pET-32. E. coli TOP10F0 strain competent cells were used for
transformation and cultured in LB agar media containing
ampicillin. The ﬁnal construct was conﬁrmed by double
digestion by Xba I-Xho I and by PCR using up-sipC-F and
down-sipC-R primers.
3. Results
DNA was successfully extracted and PCR ampliﬁed products
for ﬂanking regions of sipC and kan genes on 1% agarose gel
revealed 320 bp, 206 bp and 835 bp fragments, respectively
(Figure 1).
In the next step, the up and down regions of sipC gene of S.
typhimurium and kan gene were cloned with TA cloning tech-
nique in pGEM T-easy vector successfully, separately
(Figure 2).
Plasmid puriﬁcation and Xba I, Bgl II, Sac I and Xho I re-
striction endonuclease digestion of pET-32-sipC up-kan-sipC
down recombinant plasmid conﬁrmed the correction of up and
down regions of sipC gene of S. typhimurium and kan gene
cloning (Figure 3). A 7261 bp large fragment was related to
pET-32 vector (5900 bp) and 320, 206 and 835 fragments were
up and down regions of sipC gene and kan gene bands,





Figure 1. Agarose gel of PCR ampliﬁed products of ﬂanking regions of
sipC gene and kan gene.
Line M: 100 bp DNA marker (Fermentas, Germany); Lines 1 and 2: Up and
down regions of sipC gene, respectively; Line 3: kan gene; Line 4: PCR
negative control sample without bacterial DNA.
Figure 3. Digested pET-32 recombinant plasmid.
Analysis of digested pET-32-sipC up-kan-sipC-down recombinant plasmid
was performed using Xba I, Bgl II, Sac I and Xho I restriction endonuclease
enzymes. Line M: 1 kb DNA ladder (Fermentas, Germany); Lines 1, 2 and
3: Digested pET-32-sipC up-kan-sipC-down recombinant vector to frag-
ments of up, kan and down regions respectively; Line 4: pET-32-sipC up-
kan-sipC-down recombinant vector using Xba I and Xho I restriction en-
zymes to sipC up-kan-sipC-down recombinant fragment; Line 5: pET-32
vector without inserted sequence.
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S. enterica is a facultative intracellular pathogen of universal
signiﬁcance and Gram-negative enteric bacterium [18]. While
some have a restricted host range, for example the serovars
typhi and pullorum are restricted to humans and chickens and
most of the S. enterica serovars can infect a broad range of
cold and warm-blooded animals and humans. S. enterica in-
fects its hosts by the oral route and causes two types of disease:
a gastroenteritis determined by the extension of bacteria in the
intestinal tract and typhoid fever that determined by the inva-
sion of the systemic compartment [19,20]. SipC is a Salmonella
actin-binding protein that nucleates actin ﬁlament formation
[12]. This protein was found to enhance the entry of wild-type S.
Typhimurium into cultured cells, by interacting with phospho-
lipid membranes and oligomerizing in solution. Research to
date on sipC genes and SipC proteins that have been obtained,
further study of the molecular properties and performance are
discussed. Nuclear actin-related activity displacement factor
SipC was placed under study by Chang et al. who reported that
the central region of the protein SipC for nuclear actin and the
C-terminal amino acid region for transfer factors are required
[21,22]. Gene cloning allows scientists to ﬁnd exclusive genes,
cut them out and insert them into the genome of another
organism and is the act of making copies of a single gene.
Genetic engineering is the process of cloning genes into new
organisms to change the protein product. Bacterial plasmids
used in gene cloning naturally contain antibiotic resistance
genes [23]. He CH et al. [24] constructed a recombinant
plasmid based on AAV gene. This gene carried human
endothelial nitric oxide synthase. The study by He CH et al.
showed that pSNAV-eNOS was successfully constructed with
the ability to express human endothelial nitric oxide synthase
mRNA in cultured animals and humans cells, which is similar
to the results of our study, but the plasmid and restriction
enzyme of that research differed from those of our study [24].
The study of cloning of the encoding enterohemorrhagic
E. coli Shiga-like toxin subunits to pGEM T-easy vector
showed that cloning of this gene was successful and their
ﬁndings were similar to this study [25]. Another study of
Peerayeh SN et al. [26] in Iran, constructed a recombinant
vector based on UreB122 gene that carried the urease of
Helicobacter pylori. Prokaryote expression vector pET-32a
was inserted with UreB122 gene. The recombinant vector was
used to transform the competent E. coli DH5a. This study
showed that pET-32a-UreB122 was successfully constructed
and the expression of recombinant protein was induced by
isopropythio-b-D-galctoside at different concentrations [26].
Haghi et al. generated a gene construct based on porA gene
[27]. This protein (PorA) is a major member of the outer
membrane of Neisseria meningitidis and functions as a
cationic protein. porA was cloned into prokaryotic expression
vector pET-32a and recombinant vector was transformed into
competent Origami B (DE3) cells. Haghi et al. study showed
that pET-32a-porA was successfully constructed and recombi-
nant protein was overexpressed, which is similar to our study
[27]. A gene construct to vacB gene deletion of Brucella
melitensis (B. melitensis) vacB gene that was generated by
Iranian researchers in 2012 is an important gene of
B. melitensis that encoded a RNase R. This construct carries a
kanamycin resistance gene replacement in downstream and
upstream region of vacB gene of B. melitensis. Resultsshowed that cloning of this gene was successful and their
ﬁndings are similar to our research [16]. In another study in
China, a recombinant vector for deletion of yncD gene in
S. enterica was constructed. The yncD gene encodes a
putative TonB-dependent transporters and was identiﬁed
recently as an in vivo induced antigen [28]. In this study, yncD
deletion mutant was successfully constructed in pYG4 vector,
which is similar to the results of the present research [28]. The
recombinant bacteria have become a useful instrument in
various aspects. In this research, we have constructed the new
recombinant plasmid carrying a kanamycin resistance gene
replacement in up and down regions of sipC gene of S.
typhimurium by improving the plasmid of E. coli.
In conclusion our results showed that sipC gene was cloned
and subcloned in E. coli successfully. The recombinant gene
construct has became a useful tool in various aspects on basic
knowledge and applied science. In this research, we have con-
structed a novel recombinant gene construct that carries a
kanamycin resistance gene replacement of S. typhimurium
native sipC gene with sipC up-kan-sipC down fragment using
homologous recombination technique. The new recombinant
construct (pET-32-sipC up-kan-sipC dwon) in this study can be
useful for genetics engineering. According to the results of the
present study, gene construct that was produced can be used for
sipC gene deletion and then manipulated strain can be used for
engineering attenuated vaccine against S. typhimurium in future
researches.
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